CARCINOMA OF THE PROSTATE
- 5 December 1942
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 120 (14), 1099-1102
- https://doi.org/10.1001/jama.1942.02830490019004
Abstract
Twenty-five years ago Dr. Charles Mayo said "No matter what you do for carcinoma of the prostate, you do the wrong thing." Today this is not true. We can relieve the urinary obstruction by transurethral resection, cause regression of the primary tumor by irradiation and relieve the metastatic pain in most cases by high voltage roentgen therapy to the spine or glandular focus. Further relief from pain, if necessary, can be afforded by spinal injection of absolute alcohol or section of the sensory tracts of the cord. Within the last two years a new approach to therapy for carcinoma of the prostate has been offered. This paper is not a comprehensive symposium on endocrine therapy for carcinoma of the prostate. The various phases of this subject have been discussed in other papers. The relationship of glandular products to activation of prostatic epithelium and carcinoma of the prostate has been thoroughlyThis publication has 2 references indexed in Scilit:
- SERUM AND TISSUE PHOSPHATASE DETERMINATIONSJAMA, 1941
- AN “ ACID ” PHOSPHATASE OCCURRING IN THE SERUM OF PATIENTS WITH METASTASIZING CARCINOMA OF THE PROSTATE GLANDJournal of Clinical Investigation, 1938